Piper Jaffray Companies restated their overweight rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a research report report published on Thursday morning, The Fly reports. The firm currently has a $610.00 price objective on the medical equipment provider’s stock.
Several other equities analysts have also commented on the company. BidaskClub lowered Intuitive Surgical from a strong-buy rating to a buy rating in a research report on Wednesday, January 30th. Cantor Fitzgerald reiterated a buy rating and set a $620.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 25th. Stifel Nicolaus reduced their price objective on Intuitive Surgical from $600.00 to $570.00 and set a buy rating on the stock in a research report on Friday, January 25th. Citigroup reduced their price objective on Intuitive Surgical from $601.00 to $560.00 and set a buy rating on the stock in a research report on Wednesday, January 2nd. Finally, Zacks Investment Research upgraded Intuitive Surgical from a hold rating to a buy rating and set a $540.00 price objective on the stock in a research report on Wednesday, December 19th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. Intuitive Surgical currently has an average rating of Buy and an average price target of $579.18.
Shares of NASDAQ ISRG opened at $528.06 on Thursday. The stock has a market capitalization of $60.92 billion, a price-to-earnings ratio of 56.18, a price-to-earnings-growth ratio of 4.15 and a beta of 1.10. Intuitive Surgical has a twelve month low of $429.04 and a twelve month high of $589.32.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). The business had revenue of $974.00 million during the quarter, compared to the consensus estimate of $975.27 million. Intuitive Surgical had a return on equity of 17.85% and a net margin of 29.78%. Intuitive Surgical’s revenue was up 14.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.44 earnings per share. On average, equities analysts predict that Intuitive Surgical will post 9.9 earnings per share for the current fiscal year.
In related news, CEO Gary S. Guthart sold 28,152 shares of the stock in a transaction dated Monday, February 4th. The stock was sold at an average price of $520.47, for a total transaction of $14,652,271.44. Following the completion of the sale, the chief executive officer now directly owns 379,452 shares in the company, valued at approximately $197,493,382.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Jamie Samath sold 458 shares of the stock in a transaction dated Tuesday, January 29th. The shares were sold at an average price of $500.03, for a total value of $229,013.74. Following the sale, the vice president now owns 198 shares of the company’s stock, valued at $99,005.94. The disclosure for this sale can be found here. Insiders have sold a total of 42,284 shares of company stock valued at $22,205,382 over the last 90 days. 1.70% of the stock is currently owned by company insiders.
Hedge funds have recently modified their holdings of the stock. Stone House Investment Management LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at about $31,000. Laurel Wealth Advisors LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $32,000. Athena Capital Advisors LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $33,000. Financial Advantage Inc. purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Liberty Wealth Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $37,000. Institutional investors own 84.91% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: How Do Investors Open a Backdoor Roth IRA?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.